Skip to content

The assessment of bone graft vitality and ingrowth in posterior lumbar fusion (PLIF) using 18F-PET-CT scan.

The assessment of bone graft vitality and ingrowth in posterior lumbar fusion (PLIF) using 18F-PET-CT scan. - PLIF using 18F-PET-CT

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON39166
Enrollment
20
Registered
2011-08-01
Start date
2011-10-03
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lumbar spondylolisthesis shift vertebrae

Interventions

None listed

Sponsors

Medisch Universitair Ziekenhuis Maastricht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Age 18-65 years BMI less than 30 (i.e., non-obese) Able to speak and write dutch (questionnaires, patient information, informed consent) Spondylolisthesis L4-L5 or L5-S1, grade I or II Informed consent agreed Prepared to adhere to follow-up examinations

Exclusion criteria

Exclusion criteria: Pregnant or trying to conceive Earlier operative interventions lower lumbar spine Earlier lumbar spondylodiscitis Active or recent infection Active or recent malignancy Postradiation lumbar region Inflammatory disease Deformity General locomotor disease, e.g. multiple sclerosis, Parkinson disease

Design outcomes

Primary

MeasureTime frame
(i) Osteoblastic activity (i.e., vitality) and integrity of the bone graft by 18F-PET-CT scan at 6 weeks and 12 months postoperative. (ii) Intercorporal bony fusion by (dynamic) plain radiographs (at 6 weeks and 12 months postop, regular patient care) and a CT-scan (at 12 months postoperative).

Secondary

MeasureTime frame
Improvement in the following clinical outcomes measurements as assessed after 6 weeks and 1 year after surgery in comparison preoperative scores: Oswestry Disability Index, Short form 36 questionnaire, visual analog scale (VAS) and quality of life (EQ-5D).

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)